Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
Status:
Withdrawn
Trial end date:
1997-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical efficacy of the buprenorphine/naloxone
combination tablet for alternate-day dosing and determine whether multiples of the daily dose
are necessary to maintain an effective alternate day dosing regimen.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Heroin Naloxone